Here are some key points about Zepbound: Composition and function: Contains tirzepatide, a compound also present in the diabetes medication Mounjaro Includes semaglutide and an additional hormone, GIP, to increase insulin secretion further and decrease appetite Acts as a dual agonist, activating both GLP-1 and GIP receptors Dosage and administration: Administered as a 2.5 mg weekly injection for the first month, then potentially increased to 5 mg weekly Dosage can be adjusted, with a maximum of 15 mg per week depending on individual needs and doctors guidance Indications and usage: Approved for use in adults 18 years and older with a body mass index (BMI) of 30 or higher (obese), or a BMI of 27 or higher (overweight) with at least one weight-related health condition To be used alongside a reduced-calorie diet and increased physical activity for optimal results Continuous usage may be necessary for maintaining weight loss, and patients should consider the benefits in relation to potential side effects and costs The efficacy of Zepbound in aiding weight loss is notable, with clinical trials showcasing significant results

Some appeals to stay on Zepbound have been approved and other people have been able to switch to Wegovy with only mild side effects, but the change has been disruptive for many patients and their doctors
No pharmacy visits required
Elevate Health states that medication typically ships within 7 to 10 business days after approval
By supporting better blood sugar control and acting on the hunger and satiety centers in the brain, this prescription medication supports patients in reaching their weight loss goals when its used alongside lifestyle improvements
The semaglutide side effect profile and tirzepatide side effect profile differ in important ways, even though both are GLP-1 agonists